Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
Writing Group for the TRIGR Study Group; Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T, de Beaufort C, Dosch HM, Dupre J, Fraser WD, Howard N, Ilonen J, Konrad D, Kordonouri O, Krischer JP, Lawson ML, Ludvigsson J, Madacsy L, Mahon JL, Ormisson A, Palmer JP, Pozzilli P, Savilahti E, Serrano-Rios M, Songini M, Taback S, Vaarala O, White NH, Virtanen SM, Wasikowa R.
Writing Group for the TRIGR Study Group, et al. Among authors: al taji e.
JAMA. 2018 Jan 2;319(1):38-48. doi: 10.1001/jama.2017.19826.
JAMA. 2018.
PMID: 29297078
Free PMC article.
Clinical Trial.